Year: 2025
Type: article
Abstract: The NCCN Guidelines for Myelodysplastic Syndromes (MDS) provide recommendations for the evaluation, diagnosis, and comprehensive care of patients with MDS based on a review of recent clinical evidence that has led to important advances in treatment or has yielded new information on biologic factors that may have prognostic significance in MDS. The multidisciplinary panel of MDS experts is convened at least on an annual basis. During the annual meeting, the panel evaluates new and emerging data to inform their recommendations. These NCCN Guidelines Insights review the recent updates, including treatment recommendations both for lower-risk and higher-risk MDS, preference stratification of therapeutic agents, and emerging data on novel therapeutics.
Authors: Peter L. Greenberg, Richard M. Stone, Yasmin Abaza, Aref Al-Kali, Sarah Anand, Brian Ball, John M. Bennett, Uma Borate, Andrew M. Brunner, Wanxing Chai-Ho, Peter Curtin, Amy E. DeZern, Karin Gaensler, Zhubin Gahvari, Guillermo Garcia-Manero, Elizabeth A. Griffiths, Tamanna Haque, Meagan Jacoby, Brian A. Jonas, Sioban Keel, Rashmi Khanal, Ashwin Kishtagari, Yazan Madanat, Lori J. Maness, Shannon R. McCurdy, Christine McMahon, Olatoyosi Odenike, Afaf Osman, Vishnu V. Reddy, David A. Sallman, Hamid Sayar, Rory Shallis, Abhay Singh, Tiffany Tanaka, Swapna Thota, Emily Kovach, Jamie Nguyen, Cindy Hochstetler
Institutions: Stanford Cancer Institute, Dana-Farber Brigham Cancer Center, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), U-M Rogel Cancer Center, City Of Hope National Medical Center, University of Rochester, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Massachusetts General Hospital, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, UCSF Helen Diller Family Comprehensive Cancer Center, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, The University of Texas MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center, Memorial Sloan Kettering Cancer Center, Barnes-Jewish Hospital, Alvin J. Siteman Cancer Center, UC Davis Comprehensive Cancer Center, Fred Hutch Cancer Center, Fox Chase Cancer Center, Vanderbilt University, Vanderbilt-Ingram Cancer Center, The University of Texas Southwestern Medical Center, Fred and Pamela Buffett Cancer Center, Abramson Cancer Center, University of Pennsylvania, University of Colorado Cancer Center, University of Chicago Medicine Comprehensive Cancer Center, Huntsman Cancer Institute, O'Neal Comprehensive Cancer Center, Moffitt Cancer Center, Indiana University Health, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Yale Cancer Center, Smilow Cancer Hospital, Cleveland Clinic, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center, Moores Cancer Center, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, National Comprehensive Cancer Network
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4408365113